AUTHOREA
Log in
Sign Up
Browse Preprints
LOG IN
SIGN UP
loading page
this is for holding javascript data
Download PDF
DOWNLOAD
Download ZIP
Download LaTeX
Download JATS XML
Track citations
Fork (make a copy)
190
33
Emergent data influences the risk/benefit assessment of hemophilia gene therapy using recombinant adeno-associated virus.
John Puetz
John Puetz
Corresponding Author:
[email protected]
Author Profile
×
OK
